FECAL & GASTRIC OCCULT BLOOD TEST



Similar documents
Chapter. Guaiac Screening CHAPTER 4: GUAIAC TESTING SCREENING FOR OCCULT BLOOD. Page 1 of 5 Guaiac doc 6/24/2005

Contents. Approved by: Kent Lewandrowski, M.D. 6/1/2005 Written/Updated by: Gino Pagnani Date: 4/3/09

OneStep Fecal Occult Blood RapiDip InstaTest. Cat #

Vaginal ph Test (ph Hydrion TM Paper )

COLORECTAL CANCER SCREENING

Crime Scene Unit Presumptive Testing Procedures. Evidence Collection Division

Chapter 14 Urinalysis, Body Fluids and Other Specimens. Objectives:

Determination of Vitamin C of Citrus Juices. by Dr. Walter Scharf and Dr. Charles Malerich Natural Sciences, Baruch College New York, NY 10010

Vitamin C Content of Fruit Juice

Chemical reaction (slow): Enzyme-catalyzed reaction (much faster):

BuyNuezdelaIndia.com

Maintaining Proper Bowel Elimination

Dissolving of sodium hydroxide generates heat. Take care in handling the dilution container.

INSTRUCTIONS FOR USE HUMIRA 40 MG/0.8 ML SINGLE-USE PEN

INSTRUCTIONS FOR USE HUMIRA 40 MG/0.8 ML, 20 MG/0.4 ML AND 10 MG/0.2 ML SINGLE-USE PREFILLED SYRINGE

Factors Affecting Enzyme Activity

Colorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society

Medication Guide. Serious loss of body fluid (dehydration) and changes in blood salts (electrolytes) in your blood.

Laboratory 5: Properties of Enzymes

INTRODUCTION TO CLINICAL PRACTICE AND CLINICAL SKILLS 2nd Year MEDICAL YEAR 2009/2010

BLOOD COLLECTION. How much blood is donated each year and how much is used?

Colorectal Cancer Screening

CRMC Laboratory Draw Station is located in the Out Patient Services area. We are available 6AM to 6PM daily.

ABORhCard. ABORhCard Package Insert ABO and Rh Blood Grouping Device

Gastrointestinal Bleeding

URINE DIPSTICK Multistix 10SG

STEP-BY-STEP INSTRUCTIONS FOR INVESTIGATIONAL USE. Rapid HCV Antibody Test FOR ORAQUICK RAPID HCV ANTIBODY TEST

How Does a Doctor Test for AIDS?

Oxivir Tb and Accelerated Hydrogen Peroxide (AHP) Frequently Asked Questions

URINE COLLECTION, PREPARATION AND HANDLING

Colorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society

SAMPLE PROCEDURE , 09/11

By Anne C. Travis, M.D., M.Sc. and John R. Saltzman, M.D., FACG Brigham and Women's Hospital Harvard Medical School Boston, MA

IgM ELISA. For the quantitative determination of IgM in human serum and plasma. For Research Use Only. Not For Use In Diagnostic Procedures.

GI Bleeding. Thomas S.Foster,Pharm.D. PHR 961 Integrated Therapeutics

OBJECTIVES: Visitors learn what an antioxidant is and how it behaves. They also learn how to test for the presence of vitamin C..

Return to Lab Menu. Acids and Bases in Your House

Colonoscopy Preparation - Standard

What Forensics Information Does Blood Typing Provide?

FUNCTIONAL BOWEL DISORDERS

Mouse IgM ELISA. Cat. No. KT-407 K-ASSAY. For the quantitative determination of IgM in mouse biological samples. For Research Use Only. 1 Rev.

All About Your Peripherally Inserted Central Catheter (PICC)

Florida Nursing Assistant Academy #2926 COURSE SYLLABUS

Prevent Bleeding When Taking Blood Thinners

Managing Acute Side Effects of Prostate Radiation Therapy

PACKAGE LEAFLET: INFORMATION FOR THE USER. PARACETAMOL MACOPHARMA 10 mg/ml, solution for infusion. Paracetamol

Your Guide to Coumadin / Warfarin Therapy

ACID-BASE TITRATIONS: DETERMINATION OF CARBONATE BY TITRATION WITH HYDROCHLORIC ACID BACKGROUND

10-ml Graduated cylinder 40 ml 3% Hydrogen peroxide solution (found in stores) Straight-edged razor blade Scissors and Forceps (tweezers)

Colon Cancer. What Is Colon Cancer? What Are the Screening Methods?

UW MEDICINE PATIENT EDUCATION. Xofigo Therapy. For metastatic prostate cancer. What is Xofigo? How does it work?

A. ADMINISTERING SUBCUTANEOUS MEDICATIONS INTERMITTENTLY/CONTINUOUSLY B. (SUBCUTANEOUS INFUSION) HYDRODERMOCLYSIS

PART I: PREPARATION OF SOLUTIONS AND STANDARDIZATION OF A BASE

FAQs about Warfarin (brand name Coumadin )

Anti-Zona Pellucida Antibody Latex Agglutination Test

Reducing Medication Mismanagement in Adult Care Residences

Vitamin C Content of Foods

The Digestive System: Where does food go? Teacher Version

CK-MB TEST CARD 004A302

not appearance. ADHESIVE SYSTEMS CORIAN As an integral part of its sheet and shape products, DuPont has developed a special adhesive.

(8 years or younger)

Colonoscopy or Upper GI Endoscopy

Determination of Specific Nutrients in Various Foods. Abstract. Humans need to consume food compounds such as carbohydrates, proteins, fats,

Luminol Test PROCESS SKILLS SCIENCE TOPICS VOCABULARY

6 Body Fluid Stains and Standards

The following document includes information about:

DRUG TESTING The Analysis of Some Over-the-Counter Drugs 2004 by David A. Katz. All rights reserved.

colon cancer Talk to your doctor about getting tested for colon cancer. They know how to prevent and you can, too. Take a look inside.

CHECK LIST FOR COLONOSCOPY 2 DAY PREP

Experiment 7: Titration of an Antacid

Name. Lab 3: ENZYMES. In this lab, you ll investigate some of the properties of enzymes.

THE ACTIVITY OF LACTASE

LAB TOPIC 4: ENZYMES. Enzyme catalyzed reactions can be expressed in the following way:

How To Prepare and Give a Prefilled Syringe Injection

Nutritional Glossary. Index of Contents

Textbook: Chapter 12 pages , Chapter 13 pages

The degree of liver inflammation or damage (grade) Presence and extent of fatty liver or other metabolic liver diseases

TEST METHOD VERIFICATION AND VALIDATION

LAB 14 ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)

Objectives At the completion of this module, unlicensed assistive personnel (UAP) should be able to:

Quality Requirements of a Point of Care Testing Service

6 Characterization of Casein and Bovine Serum Albumin

Colon and Rectal Cancer

Catalytic Activity of Enzymes

Biopharmaceuticals and Biotechnology Unit 2 Student Handout. DNA Biotechnology and Enzymes

PCR and Sequencing Reaction Clean-Up Kit (Magnetic Bead System) 50 preps Product #60200

Bydureon 2 mg powder and solvent for prolonged-release suspension for injection in pre-filled pen How to use Bydureon pre-filled pen

Cold Agglutination Titer detecting Cold Reacting Antibodies

POC.PC.17 Point of Care Testing AMNISURE PROCEDURE FOR RUPTURED FETAL MEMBRANES TABLE OF CONTENTS. 1.0 Principle of Procedure.. 2

Positron Emission Tomography - For Patients

Lead Testing and On Site Calibration for Water Testing Detection Range: 2 100ppb

experiment5 Understanding and applying the concept of limiting reagents. Learning how to perform a vacuum filtration.

EXPERIMENT 20: Determination of ph of Common Substances

Geriatric Medicine. Advice on. Constipation and Laxatives

Fecal Incontinence. What is fecal incontinence?

PATIENT INFORMATION. Medicine To Treat: D iabetes. What You Need to Know About. Insulin

HED\ED:NS-BL 037-3rd

Blood Sampling in Sheep AS-557-W

Nurse Initiated Medications Procedure

Transcription:

PROCEDURE # 945.8022 PREPARED BY DATE ADOPTED SUPERSEDES PROCEDURE # Janet Swaim 1/2004 POC 3 and 5 REVIEW DATE REVISION DATE SIGNATURE DISTRIBUTED TO # COPIES DISTRIBUTED TO # COPIES Torresdale Campus Laboratory 1 Hospital Intranet 1 Dept. of Pathology & Laboratory Medicine Page 1 of 5 Fecal & Gastric Occult Blood Test.doc

PRINCIPLE: The use of guaiac as a test for the presence of blood is based on the oxidation of phenolic compounds present in guaiac to quinines, resulting in the production of a blue color. If blood is present, the heme portion of the hemoglobin molecule can function in a pseudoenzymatic manner, catalyzing the release of oxygen from hydrogen peroxide, which in turn causes the oxidation of guaiac. HemaPrompt is a version of the laboratory guaiac slide test for fecal or gastric occult blood, and is composed of guaiac-impregnated paper mounted on a cardboard frame which permits sample applications to one side with development and interpretation from reverse side. Feces or gastric contents containing occult blood contacts the guaiac impregnated paper and a pseudoperoxidase reaction occurs when developing solution is brought into contact with the guaiac paper by pulling the tab. The test paper will turn blue in less than 60 seconds in the presence of more than 2mg hemoglobin/gm of feces, and will gradually fade in 5-15 minutes. It will also turn blue in presence of more than 0.01 mg hemoglobin/ml of gastric fluid in less than 60 seconds. Monitors on the guaiac slide indicate if the chemicals are functioning correctly. OPERATORS: Testing is performed by physicians whose competency is accessed at the time of credentialing. Testing is also performed by registered nurses and licensed practical nurses who are properly trained in the procedure. They must demonstrate their proficiency in performing CAP surveys, quality control and patient testing activity in their annual skills lab competency or peer review. SPECIMEN: Patient Preparation: 1. Fecal Occult Blood: In the acute situation no particular preparation will be possible, but for screening purposes a special diet as described below is recommended to decrease the possibility of false positive results. On the one hand, dispensing with such a diet for initial screening purpose may increase patient compliance but a positive result under these circumstances would indicate the need to repeat the test in which a special diet two days prior to and during the three day test period is followed. This diet should EXCLUDE red and rare meats, horseradish, raw fruits and vegetables like broccoli, cauliflower, red radish, cantaloupe, parsnips and turnips, or other high peroxidase containing vegetables, which can cause false positive results. An acceptable diet could include cooked fruit and vegetables such as spinach and corn as well as lettuce, prunes, grapes, and apples. Cereal, and well cooked fish and fowl are also acceptable. If any of the recommended foods are known to cause discomfort, the patient should consult his or her physician. Because gastro-intestinal lesions may bleed intermittently and blood in feces is not distributed uniformly, all patients who test positive regardless of diet should be followed up with additional diagnostic procedures. Certain medications such as aspirin, indomethacin, phenylbutazone, reserpine, corticosteroids and nonsteroidal anti-inflammatory drugs can cause gastro-intestinal bleeding and thus give positive reactions. Dosages of greater than 250 mg of Vitamin C per day have been shown to cause false negative results, while iron containing compounds have been mentioned as a cause of false positive reactions. On the advice of the physician, these medications might be temporarily discontinued for 7 days prior to and during the test period. 2. Gastric Occult Blood: Elective collection of gastric juice is rarely conducted. False positive and false negative reactions can be caused by medications and foods such as mentioned above. In addition, using a guaiac based test with an unbuffered developer, certain histamine (H2) antagonists such as cimetidine (Tagamet) have been shown to cause false positive reactions as with iron, and false negative reactions can result from low ph, but because of the buffering of the developer used in HemaPrompt, interfering reactions by recommended dosage of ranitidine (300mg), ferrous sulfate (300mg),cimetidine (300mg) or antacids (Mylanta10-20 ml) have not been observed. Type: Stool and/or gastric juices. Dept. of Pathology & Laboratory Medicine Page 2 of 5 Fecal & Gastric Occult Blood Test.doc

PATIENT IDENTIFICATION: The patient is identified using their identification band to verify name and date of birth. At the Health Center Clinic, the patient or patient s parent or legal guardian is asked to state the patient s name and date of birth. The HemaPrompt card is labeled with the name and date of birth immediately. Handling Conditions: Blood in bulk stool is unstable, so once it is collected, the sample is applied to the test card immediately. Feces can be obtained by direct rectal exam, but for screening purposes stool samples should not be collected if the patient is experiencing menstrual bleeding, constipation bleeding, bleeding hemorrhoids or when rectal suppositories or medication is being used. It is recommended that smears be collected from two different areas of each stool from three consecutive bowel movements as closely spaced in time as possible, or by the physician following a rectal exam. Using toilet paper, a specimen is taken from stool smeared on the bowl and above the toilet water level, from the toilet paper used following defecation, or from a specimen caught in a clean cup. Application to the slide may be performed from the gloved finger (as after a rectal exam), applicator, or by use of the toilet paper described above. It is important that the stool specimen is applied as a thin smear to each of the slide windows and that no more than 4 days should elapse between preparation and testing, with patients being instructed to return all slides to the physician as soon as possible. Rehydration of the specimen is neither necessary nor recommended. Gastric contents obtained from the nasogastric tube or vomitus can be applied directly from the nasogastric tube or by means of a cotton tipped swab. In each case only a thin smear of material is applied to the test area on the slide and developed (by pulling the tab as described on each slide) immediately and read within one minute. The specimen as applied to the slide or by itself may be stored up to 24 hours at room temperatures or up to 5 days at 15-30º C before developing. Occasionally gastric samples applied to the slide may appear green in which circumstances only the formation of blue can be regarded as positive. Patient specimens and all materials that come in contact with them should be handled as potentially infectious and disposed of with proper precaution. Do not allow contact with skin or mucous membranes. EQUIPMENT AND MATERIALS Equipment: N/A Materials: Guaiac impregnated paper and developing solution are both mounted on each slide, as is a control monitor. The developing solution of 60-70% denatured ethyl alcohol and approximately 6% hydrogen peroxide diluted approximately 20% by a buffering mixture is contained within a developing pad and is exposed after pulling the tab. The positive monitor contains a hematoid equivalent to a minimum of 2.0 mg Hb per gram feces. The fecal specimen is usually applied directly by the gloved finger, from toilet paper or by applicator (as supplied). Gastric specimens can be applied directly from the nasogastric tube or by obtaining a specimen from the container of gastric juice by means of the applicator supplied or by a clean cotton tipped swab (not supplied). There are 50 slides with applicators in each box (Catalogue Number HPfg). Important Note: Current U.S. Postal Regulations prohibit mailing completed test slides in standard envelopes. Performance Parameters: Feces: Hemoglobin was diluted to the following concentrations: 1,2,4 and 6 mg/ml, equivalent to 0.1, 0.2, 0.4 and 0. 6 grams hemoglobin per 100 grams of stool or approximately 1,2,4 and 6 mls. of blood per 100 grams of stool. These dilutions were used to test the sensitivity of HemaPrompt fg as well as to compare the reactions of one other commercially available guaiac slide test concurrently with HemaPrompt. In testing with blood-spiked normal stool, HemaPrompt fg reacted positively at hemoglobin concentrations of 2mg/ml or greater, in less than 60 seconds, with no reactions below this concentration. Hydrating stool (unless dried by age) by adding distilled water may produce reactions below this level by eluting blood out or the sample and onto the test paper and false positive reactions are possible. Gastric juice: The reactions of HemaPrompt fg to the presence of blood in gastric juice were compared to one other commercial gastric occult blood test, and tested in the following manner. Twenty batches of gastric juice obtained by aspiration from different individuals, ten with gastric pathology and ten from healthy volunteers. Dept. of Pathology & Laboratory Medicine Page 3 of 5 Fecal & Gastric Occult Blood Test.doc

Each sample was divided into 5 further samples and the ph in each adjusted to produce samples at ph 1.0, 2.5, 4.0, 6.0 and 8.0 respectively (simulating the varying phs likely to be encountered in gastric juices). Each of these samples had blood added so as to provide hemoglobin levels of 0.005, 0.01, 0.05, 0.1, 0.2, 0.5, and 1 mg hemoglobin / ml. A total of 35 samples were available for testing, reproducibility, and comparison to another commercially available product. These test results showed excellent precision and reproducibility at all ph and blood levels. They were performed 4 times the same day, and on three subsequent days on the same samples. Levels of hemoglobin above 0.02 mg/ml gastric juice always produced a reaction in less than 60 seconds and were negative below this level. Similar results were seen with another commercially available test designed for gastric occult blood and it was found that this product reacted in a like manner. Furthermore, concentrations of ranitidine, cimetidine, ferrous gluconate, and an antacid (Mylanta) to be expected in the stomach after a maximum recommended dose did not alter the results. All monitors reacted in the expected manner (positive control turned blue). Exposing the guaiac paper to UV light for ten minutes inactivated the expected reaction. It was concluded that with stool, HemaPrompt fg reacted positively and definitely to all hemoglobin levels above 2mg/g of stool at which level another commercially available guaiac slide test, when used in its indicated manner, reacted comparatively and similarly. It was further concluded that with gastric juice, HemaPrompt fg reacted positively and reliably to hemoglobin added to levels above 100mcg / ml of gastric juice. Storage Requirements: Each slide is equipped with controls to monitor the effectiveness of the chemicals and hence the test itself. The positive control must turn blue. Failure of the control to produce the appropriate color reaction is indicative of product deterioration and the test results are invalid. HemaPrompt slides should be stored at room temperature (15-30C) and should be protected from heat, sunlight, fluorescent light, U-V radiation, humidity, volatile chemicals and gases. Do not refrigerate or freeze. They are stable until the expiration date indicated on each slide, after which time the slide is not be used. CALIBRATION: None Required QUALITY CONTROL: Each shipment of Hempapromt cards is tested with NERL controls upon arrival at the Torresdale campus. Two cards are pulled from every lot in the shipment, and negative and positive control are run on each lot and the results are recorded on the Hemaprompt QC log. SPD at Torresdale ships the tested Hemaprompt boxes to the Bucks and Frankford campuses. The records of the QC are stored in the Urinalysis department at the Torresdale campus. Each slide is equipped with controls to monitor the effectiveness of the chemicals and hence the test itself. The positive control must turn blue. The clear area surrounding the positive control functions as a negative control, (i.e., it should remain clear). Failure of the controls to produce the appropriate color reaction is indicative of product deterioration and the test results are invalid. PROCEDURE STEPWISE: There are two windows on each test card to which a stool or gastric specimen can be applied. Attached to each card there is a liquid-containing pouch which is released by pulling the tab. After the tab is pulled, you will see a "+" control on the edge of each test card which must turn blue indicating the test has functioned correctly. A blue color in the window test areas is a positive result. No blue in the test areas means no blood was detected. 1. Open the front cover of one Hemaprompt card and spread a very thin smear of the specimen on one of the windows. When testing feces, from a different area of the stool, spread a second specimen thinly on the second window. Close the card cover. 2. After closing the card cover turn to the back of the card. Grip with the left thumb and finger at the point indicated and hold the foil tab with the right thumb and finger. Alternatively lay the closed card face down flat on a table and hold in place with your left thumb at the indicated grip point. Slowly and steadily pull the foil tab all the way out to the right and off. Wait one minute after pulling the tab before reading the test result. 3. Check that the "+" indicator marked "control" has turned blue. If it has not turned blue the test card is faulty and is discarded. After one minute, inspect the indicated window test areas. Any shade of blue no matter if it is faint or a small speck in either one of the test areas is a positive reaction and indicates that blood is Dept. of Pathology & Laboratory Medicine Page 4 of 5 Fecal & Gastric Occult Blood Test.doc

present. Do not read after 3 minutes as the blue color may fade. After noting the results, discard (do not flush) the card and applicator safely. CALCULATIONS: None required REPORTING RESULTS: Reference Range: Negative. Procedure for Abnormal Results: No special handling pertains. Reporting Format: All results are recorded on the Point of Care Form in the clinic. Physicians use the sticker provided on the card to record lot numbers and results. All recorded results must be checked against the visual results prior to discarding slide. PROCEDURE NOTES: 1. Any trace of blue coloration is to be regarded as a positive for occult blood. An absence of blue indicates no detectable occult blood. These results are read at room temperature (16-32C) after 30 seconds and before 1 minute of pulling the tab. Within this time period, the proper functioning of the reagents is indicated by the positive monitor turning blue; should the monitor reaction be different, the test result is invalid. Contact Aerscher at 800-474-4072 for assistance if an invalid test result occurs. 2. Colorblind persons can not interpret the results. 3. Neither the intensity nor the shade of blue from the positive Control Monitor can be used as a reference for the appearance of positive test results. LIMITATIONS OF THE PROCEDURE: Gastrointestinal cancers, adenomas and ulcerations do not always bleed. Results cannot be considered conclusive evidence of the presence or absence of GI bleeding or pathology, and false positive or negative reactions are known to occur under certain circumstances such as a person's diet, medication, or traumatic use of a nasogastric tube (see Patient Preparation above). The test is not intended as a replacement for other diagnostic procedures and further testing and examination by the physician such as esophago-gastroscopy, sigmoidoscopy, barium enema, and imaging studies needs to be performed to determine the exact cause and source of the occult blood. REFERENCES: 1. Kratochvil J.F. Isolation and Characterization of Alpha Guaiaconic Acid. Phytochem, 10.2529-2531, 1971. 2. Grossman MI, Matsumoto KK & Lichter J. Fecal Blood Loss Produced by Oral and Intravenous Administration of Various Salicylates, Gastroenterology 40:383-388 1961. 3. Jaffe RM Kaster B Young DS & Maclowry JD. False Negative Stool Occult Blood Tests caused by Indigestion of Ascorbic Acid. Ann Int Med 83:824-826, 1975. 4. Bragshaw JR Harris E & McCurdy. The Effect of Oral Iron Therapy on the Stool Guaiac and Ortho-tolidine Reactions. Annals Int Med 59:172-179, 1963. 5. Greegor DH. Detection of Silent Colon Cancer in Routine Exam. Cancer 19:333-337, 1969. 6. Greegor DH. Occult Blood Testing for Asymptomatic Colon Cancer. Cancer 28:131-134, 1971. 7. Norfleet, RG, Rhodes, RA and Saviage K. False-Positive Hemoccult Reaction with Cimetidine. N.Engl. J Med 302-467, 1980. 8. HemaPrompt fg Package Insert. Dept. of Pathology & Laboratory Medicine Page 5 of 5 Fecal & Gastric Occult Blood Test.doc